Answers are grounded in this paper and cite their sources.
BackgroundExpanded newborn screening (ENBS) plays a crucial role in the early detection of congenital genetic, metabolic, and endocrine disorders, enabling timely interventions to reduce morbidity and mortality.In India, the screening, prevention, and management of Inborn Errors of Metabolism (IEM) are yet to be fully integrated into the national healthcare system.The aim of this study was to evaluate the feasibility, screening uptake and coverage, recall rates, and diagnostic yield of ENBS in a tertiary care centre in South India. MethodsThis retrospective observational study included 28,175 newborns screened between 2016 and 2024 using an ENBS panel covering 54 disorders.Screening data were analyzed for annual programme uptake, screening coverage, recall rates, confirmatory testing, confirmed diagnoses, diagnostic yield, and clinical follow-up. ResultsAmong 86,947 live births, 28,175 newborns underwent ENBS, corresponding to an overall screening coverage of 32.4%.Screening uptake increased from 5.1% (n=435) in 2016 to 42.1% (n=3,979) in 2024.A total of 401 infants were recalled for further evaluation (recall rate 1.4%; n=401).A total of 94 newborns were confirmed to have screened disorders, corresponding to an overall diagnostic yield of 0.3% (1 in 299 screened newborns).Congenital hypothyroidism was the most frequently detected disorder (46 cases), followed by G6PD deficiency (37 cases).Additional confirmed diagnoses included congenital adrenal hyperplasia (n=2), cystic fibrosis (n=3), fatty acid oxidation disorders (n=3), organic acid disorders (n=2), and amino acid disorders (n=1).Positive predictive value varied across conditions, with the highest observed for G6PD deficiency.Most confirmed cases received timely genetic/metabolic counseling, appropriate treatment, and follow-up. ConclusionsOver nine years, implementation of ENBS in a tertiary-care setting was associated with a substantial increase in screening uptake and enabled the identification of clinically important and potentially treatable disorders with a relatively low recall rate.These findings demonstrate the potential feasibility and clinical utility of expanded newborn screening in India and support the development of structured newborn screening and follow-up pathways within maternal and child healthcare services.
No takes yet. Share an insight, caveat, or question.
Nerakh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: